Coeptis Therapeutics Holdings (COEP) Equity Ratio (2021 - 2025)
Historic Equity Ratio for Coeptis Therapeutics Holdings (COEP) over the last 5 years, with Q3 2025 value amounting to 0.77.
- Coeptis Therapeutics Holdings' Equity Ratio rose 3836.98% to 0.77 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.77, marking a year-over-year increase of 3836.98%. This contributed to the annual value of 0.43 for FY2024, which is 14378.2% up from last year.
- Coeptis Therapeutics Holdings' Equity Ratio amounted to 0.77 in Q3 2025, which was up 3836.98% from 0.58 recorded in Q2 2025.
- In the past 5 years, Coeptis Therapeutics Holdings' Equity Ratio registered a high of 0.77 during Q3 2025, and its lowest value of 0.12 during Q1 2024.
- Its 5-year average for Equity Ratio is 0.27, with a median of 0.23 in 2022.
- In the last 5 years, Coeptis Therapeutics Holdings' Equity Ratio tumbled by 18524.23% in 2024 and then surged by 55688.39% in 2025.
- Over the past 5 years, Coeptis Therapeutics Holdings' Equity Ratio (Quarter) stood at 0.35 in 2021, then soared by 61.93% to 0.56 in 2022, then crashed by 68.35% to 0.18 in 2023, then skyrocketed by 143.78% to 0.43 in 2024, then surged by 77.33% to 0.77 in 2025.
- Its last three reported values are 0.77 in Q3 2025, 0.58 for Q2 2025, and 0.55 during Q1 2025.